VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,631,000 | -58.2% | 1,315,154 | -34.2% | 0.35% | -74.7% |
| Q4 2021 | $3,900,000 | -28.8% | 2,000,000 | 0.0% | 1.40% | -12.7% |
| Q3 2021 | $5,480,000 | -13.0% | 2,000,000 | 0.0% | 1.60% | -7.5% |
| Q2 2021 | $6,300,000 | -28.6% | 2,000,000 | -51.7% | 1.73% | -16.5% |
| Q1 2021 | $8,826,000 | +86.4% | 4,143,702 | +69.8% | 2.07% | +96.6% |
| Q4 2020 | $4,734,000 | – | 2,440,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |